de Haas, E. C., & Luijendijk, H. J. (2020). Author's reply: Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults. . European Journal of Internal Medicine, 72. https://doi.org/10.1016/j.ejim.2019.12.021

de Haas, E. C., & Luijendijk, H. J. (2019). Baloxavir for influenza: Enrichment obscured lack of effect in North-American adults. European Journal of Internal Medicine, 62, e8-e9. https://doi.org/10.1016/j.ejim.2018.12.002

Gutierrez-Achury, J., Romanos, J., Bakker, S. F., Magadi Gopalaiah, V. K., de Haas, E. C., Trynka, G., Ricano-Ponce, I., Steck, A., Chen, W-M., Onengut-Gumuscu, S., Simsek, S., Rewers, M., Mulder, C. J., Liu, E., Rich, S. S., Wijmenga, C., & Type 1 Diabet Genetics Consortium (2015). Contrasting the Genetic Background of Type 1 Diabetes and Celiac Disease Autoimmunity. Diabetes Care, 38, S37-S44. https://doi.org/10.2337/dcs15-2007

de Haas, E. C., Altena, R., Boezen, H. M., Zwart, N., Smit, A., Bakker, S., van Roon, A. M., Postma, A., Wolffenbuttel, B. H. R., Hoekstra, H., van Leeuwen, F. E., Sleijfer, D. T., & Gietema, J. (2013). Early development of the metabolic syndrome after chemotherapy for testicular cancer. Annals of Oncology, 24(3), 749-755. https://doi.org/10.1093/annonc/mds527

de Haas, E. C., Zwart, N., Meijer, C., Suurmeijer, A. J. H., Meijer, K., Guchelaar, H. J., Hoekstra, H. J., van Leeuwen, F. E., Sleijfer, D. T., Boezen, H. M., & Gietema, J. A. (2010). Association of PAI-1 gene polymorphism with survival and chemotherapy-related vascular toxicity in testicular cancer. Cancer, 116(24), 5628-5636. https://doi.org/10.1002/cncr.25300

de Haas, E. C., Oosting, S. F., Lefrandt, J. D., Wolffenbuttel, B. H. R., Sleijfer, D. T., & Gietema, J. A. (2010). The metabolic syndrome in cancer survivors. Lancet Oncology, 11(2), 193-203.

Oosting, S. F., de Haas, E. C., Links, T. P., de Bruin, D., Sluiter, W. J., de Jong, I. J., Hoekstra, H. J., Sleijfer, D. T., & Gietema, J. A. (2010). Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Annals of Oncology, 21(1), 104-108. https://doi.org/10.1093/annonc/mdp265

Nuver, J., De Haas, E. C., Van Zweeden, M., Gietema, J. A., & Meijer, C. (2010). Vascular damage in testicular cancer patients: A study on endothelial activation by bleomycin and cisplatin in vitro. ONCOLOGY REPORTS, 23(1), 247-253. https://doi.org/10.3892/or_00000630

Altena, R., de Haas, E. C., Nuver, J., Brouwer, C. A. J., van den Berg, M. P., Smit, A. J., Postma, A., Sleijfer, D. T., & Gietema, J. A. (2009). Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer. British Jounal of Cancer, 100(12), 1861-1866. https://doi.org/10.1038/sj.bjc.6605095

de Haas, E. C., Zwart, N., Meijer, C., Boezen, H. M., Suurmeijer, A. J., van der Meer, J., Hoekstra, H. J., van Leeuwen, F. E., Sleijffer, D. T., & Gietema, J. A. (2009). Association of plasminogen-activator inhibitor 1 (PAI-1) 4G/5G gene polymorphism with survival and chemotherapy-related vascular toxicity in non-seminomatous testicular cancer (TC). Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27(15_suppl), 5083. https://doi.org/10.1200/jco.2009.27.15s.5083

de Haas, E. C., di Pietro, A., Simpson, K. L., Meijer, C., Suurmeijer, A. J. H., Lancashire, L. J., Cummings, J., de Jong, S., de Vries, E. G. E., Dive, C., & Gietema, J. A. (2008). Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer. Neoplasia, 10(10), 1041-1048. https://doi.org/10.1593/neo.08620

de Haas, E. C., Zwart, N., Meijer, C., Nuver, J., Boezen, H. M., Suurmeijer, A. J. H., Hoekstra, H. J., van der Steege, G., Sleijfer, D. T., & Gietema, J. A. (2008). Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. Journal of Clinical Oncology, 26(11), 1817-1823. https://doi.org/10.1200/JCO.2007.14.1606

de Haas, E. C., Sleijfer, D. T., & Gietema, J. A. (2007). Follow-up of successfully treated testicular cancer patients: consequences of the metabolic syndrome. Annals of Oncology, 18(2), 211-212. https://doi.org/10.1093/annonc/mdl480

de Haas, E. C., Nuver, J., van den Berg, M. P., Smit, A. J., Sleijfer, D. T., & Gietema, J. A. (2006). Troponin I and cardiovascular risk stratification in patients with testicular cancer - In reply. Journal of Clinical Oncology, 24(21), 3508-3509. https://doi.org/10.1200/JCO.2006.06.8130

de Haas, EC., Nuver, J., Smit, AJ., Sleiffier, DT., & Gietema, JA. (2006). Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer: Are there implications for blood pressure management in patients receiving chemotherapy? Reply. Journal of Clinical Oncology, 24(15), 2399-2400. https://doi.org/10.1200/JCO.2006.05.8644